Panjon Ltd. (BSE: 526345) is a Indore, Madhya Pradesh-based company in the Pharmaceuticals industry. With a market capitalisation of ₹34 Cr, it ranks #4,180 by market cap among the 6,137 Indian listed companies on FinBizNet, and #54 of 63 in Pharmaceuticals. At ₹17.56 (as of 25 Oct 2026), the share price is 41.5% below its 52-week high of ₹30.00 and 8.7% above its 52-week low of ₹16.16. The share price is down 4.6% over one year and down 2.7% over three months.
| Current Price | ₹17.56 |
|---|---|
| Market Cap | ₹34 Cr |
| BSE Code | 526345 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Pharmaceuticals |
| P/E Ratio | 70.2 |
| Return on Equity | 4.32% |
| Return on Assets | 2.08% |
| 52-Week Range | ₹16.16 – ₹30.00 |
| 1-Year Price Change | -4.6% |
| 3-Month Price Change | -2.7% |
| Beta (1Y) | 0.5 |
| Headquarters | Indore, Madhya Pradesh |
| Website | www.panjon.in |
Panjon Limited manufactures and trades in consumer and pharmaceutical products in India. The company offers tablets, balms, cough syrups and drops, inhalers, hair oil, candies, digestive drops, energy drink, dental care creams, and mouth freshner, as well as awla, khajoor, chatpati, and shoppee. It sells its products under the Panjon, Hinkargiri, KERY, Percy, Swad, and Purti brand names. Panjon Limited was incorporated in 1964 and is based in Indore, India.
1. Trading-This segment operates SwadBazaar.com, an online shopping portal. 2. Manufacturing-This segment manufactures and trades in allopathic and ayurvedic medicines. 3. Pharmaceuticals-This segment markets and sells pharmaceutical products.
1. Manufacturing-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Abbott India Ltd. | ₹55,577 Cr | 35.5 | 34.46% | ₹1,814 Cr | -16.1% |
| Ajanta Pharma Limited | ₹41,591 Cr | 39 | 25.39% | ₹1,626 Cr | +36.3% |
| Emcure Pharmaceuticals Ltd | ₹34,533 Cr | 36.3 | 19.57% | ₹2,580 Cr | +31.1% |
| Piramal Pharma Ltd | ₹26,284 Cr | -79 | -4.00% | ₹2,270 Cr | -1.6% |
| RUBICON RESEARCH LIMITED | ₹24,972 Cr | 97.6 | 19.14% | ₹534 Cr | — |
| Caplin Point Laboratories Ltdte | ₹17,484 Cr | 26.9 | 19.94% | ₹610 Cr | +10.3% |
| Pfizer Ltd. | ₹17,448 Cr | 24.1 | 17.16% | ₹653 Cr | -32.1% |
| Eris Lifesciences Ltd | ₹15,877 Cr | 24.8 | 18.07% | ₹873 Cr | -30.8% |
| Panjon Ltd. | ₹34 Cr | 70.2 | 4.32% | — | -4.6% |
Listed by market capitalisation. Ratios are shown for context only.
Panjon Ltd. is trading at ₹17.56, with a market capitalisation of ₹34 Cr.
Panjon Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).
Panjon Ltd. has a P/E of 70.2 and a return on equity of 4.32%.
Panjon Ltd. is listed on the BSE under the scrip code 526345.
Panjon Ltd.'s share price is down 4.6% over one year and down 2.7% over three months. Its 52-week range is ₹16.16 to ₹30.00.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.